Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-06 Option Award |
2020-06-08 9:22 pm |
N/A 2030-06-06 |
Qualigen Therapeutics Inc. | QLGN | Korenberg Matthew E Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-06-06 Option Award |
2020-06-08 9:21 pm |
N/A 2030-06-06 |
Qualigen Therapeutics Inc. | QLGN | Lotz Christopher L. Vice President of Finance, CFO |
600,000 | $0 | 600,000 (Direct) |
View |
Ownership |
2020-05-27 7:12 pm |
N/A N/A |
Qualigen Therapeutics Inc. | QLGN | SEKISUI DIAGNOSTICS LLC 10% Owner |
0 | $0 | 1,980,233 (Direct) |
View |
| 2020-05-22 Other |
2020-05-27 6:07 pm |
2020-05-22 2024-01-31 |
Qualigen Therapeutics Inc. | QLGN | Abdul-Ahad Wajdi VP, R&D, CSO |
16,828 | $0 | 16,828 (Direct) |
View |
| 2020-05-22 Other |
2020-05-27 6:05 pm |
2020-05-22 2024-01-31 |
Qualigen Therapeutics Inc. | QLGN | Sinha Shishir K. Vice President of Operations |
35,427 | $0 | 35,427 (Direct) |
View |
| 2020-05-22 Other |
2020-05-27 6:04 pm |
2020-05-22 2024-01-31 |
Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman, President & CEO. |
257,760 | $0 | 426,952 (Direct) |
View |
| 2020-05-22 Other |
2020-05-27 6:03 pm |
2020-05-22 2024-01-31 |
Qualigen Therapeutics Inc. | QLGN | Lotz Christopher L. VP of Finance, CFO. |
87,515 | $0 | 97,356 (Direct) |
View |
| 2020-05-22 Other |
2020-05-27 6:01 pm |
2020-05-22 2027-06-26 |
Qualigen Therapeutics Inc. | QLGN | Kruger Kurt H Director |
8,857 | $0 | 8,857 (Direct) |
View |
| 2020-05-22 Other |
2020-05-27 5:59 pm |
2020-05-22 2027-06-26 |
Qualigen Therapeutics Inc. | QLGN | David Richard A. Director |
8,857 | $0 | 8,857 (Direct) |
View |
| 2020-05-18 Option Award |
2020-05-19 3:44 pm |
2020-05-18 2024-05-18 |
RITTER PHARMACEUTICALS INC | RTTR | Ritter Ira E. COB, CSO Director |
361,502 | $0 | 361,502 (Direct) |
View |
| 2020-05-18 Option Award |
2020-05-19 3:43 pm |
2020-05-18 2024-05-18 |
RITTER PHARMACEUTICALS INC | RTTR | Beck John W Chief Financial Officer |
221,566 | $0 | 221,566 (Direct) |
View |
| 2020-05-18 Option Award |
2020-05-19 3:42 pm |
2020-05-18 2024-05-18 |
RITTER PHARMACEUTICALS INC | RTTR | Ritter Andrew J CEO and President |
583,068 | $0 | 583,068 (Direct) |
View |